Abstract

Risk-based approach to leverage prior knowledge & statistical modeling during process development & process characterization of multivalent vaccines

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call